Results 171 to 180 of about 20,708 (216)
Some of the next articles are maybe not open access.
Myocarditis and Endomyocardial Biopsy
Cardiology Clinics, 1984There is little correlation between the clinical and the biopsy tissue diagnoses of myocarditis, and both are prone to false-positive and false-negative interpretations. Perhaps the most common error that leads to a false-positive clinical diagnosis of myocarditis is the preconceived but unproved notion that unexplained heart failure of sudden onset or
openaire +2 more sources
Vnitrni lekarstvi, 1992
The authors present ten years' experience with endomyocardiac biopsy of the heart (EMB) using the percutaneous, endovasal catheterization needle technique. EMB was performed in 314 patients, a total of 1362 biopsies, and for evaluation 5564 specimens of cardiac tissue were taken.
J, Fabián, J, Horák, J, Sochman
openaire +1 more source
The authors present ten years' experience with endomyocardiac biopsy of the heart (EMB) using the percutaneous, endovasal catheterization needle technique. EMB was performed in 314 patients, a total of 1362 biopsies, and for evaluation 5564 specimens of cardiac tissue were taken.
J, Fabián, J, Horák, J, Sochman
openaire +1 more source
Catheterization and Cardiovascular Diagnosis, 1977
I A, Brooksby, M M, Webb-Peploe
openaire +2 more sources
I A, Brooksby, M M, Webb-Peploe
openaire +2 more sources
JAMA, 1997
Short-term survival of cardiac allografts has increased markedly because of surveillance by protocol endomyocardial biopsies and improvements in immunosuppression, which have largely prevented graft loss from acute rejection. Currently, 85% of allograft recipients survive for 1 year, and 70% can expect to survive 5 years.
openaire +1 more source
Short-term survival of cardiac allografts has increased markedly because of surveillance by protocol endomyocardial biopsies and improvements in immunosuppression, which have largely prevented graft loss from acute rejection. Currently, 85% of allograft recipients survive for 1 year, and 70% can expect to survive 5 years.
openaire +1 more source
Cardiovascular clinics, 1987
Endomyocardial biopsy is an accepted, useful invasive tool for the analysis of human endomyocardium at the cellular and subcellular levels. It is applicable in the evaluation of specific diseases including cardiac allograft rejection, myocarditis, anthracycline cardiotoxicity, and infiltrative cardiomyopathies.
J A, Laser, R E, Fowles, J W, Mason
openaire +1 more source
Endomyocardial biopsy is an accepted, useful invasive tool for the analysis of human endomyocardium at the cellular and subcellular levels. It is applicable in the evaluation of specific diseases including cardiac allograft rejection, myocarditis, anthracycline cardiotoxicity, and infiltrative cardiomyopathies.
J A, Laser, R E, Fowles, J W, Mason
openaire +1 more source